Valuation : CVRx, Inc.

Market Cap 81.26M 69.92M 65.79M 60.1M 112M 7.67B 113M 777M 302M 3.94B 305M 298M 12.68B P/E 2026 *
-1.51x
P/E 2027 * -1.6x
Enterprise Value 91.76M 78.96M 74.29M 67.86M 127M 8.66B 127M 878M 341M 4.45B 345M 337M 14.32B EV / Sales 2026 *
1.56x
EV / Sales 2027 * 1.88x
Free-Float
80.18%
Yield 2026 *
-
Yield 2027 * -
1 day+1.33%
1 week+3.39%
Current month+3.04%
1 month-45.34%
3 months-43.31%
6 months-63.56%
Current year-57.04%
1 week 2.81
Extreme 2.81
3.18
1 month 2.2
Extreme 2.2
3.42
Current year 2.2
Extreme 2.2
9.84
1 year 2.2
Extreme 2.2
11.3
3 years 2.2
Extreme 2.2
33.14
5 years 2.2
Extreme 2.2
33.14
10 years 2.2
Extreme 2.2
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Chief Operating Officer - 01/02/2022
Chief Tech/Sci/R&D Officer 66 23/05/2024
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
13/8/26 Buy

Chief Operating Officer

26,223 0.0988%
12/8/26 Sell

Chief Operating Officer

-1,309 0.0049%
1/6/26
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+3.39%-61.00%-82.28% 81.26M
+0.32%+0.15%+14.46%+22.92% 12.69B
-0.98%-2.26%+15.25%+26.04% 6.88B
-2.33%+15.85% - - 6.54B
-2.41%-7.59%+29.38%+19.88% 5.99B
+3.02%+1.31%-18.75%+53.45% 5.21B
+0.51%-1.90%-30.30%-22.46% 3.83B
+1.70%+0.67%+46.09%-16.25% 2.09B
-2.02%-3.00%-1.85%+125.58% 1.72B
+2.63%-1.57%+48.17%-13.79% 1.64B
Average +0.18%+0.75%+4.61%+12.57% 4.67B
Weighted average by Cap. -0.22%+1.05%+10.41%+23.30%

Financials

2026 *2027 *
Net sales 58.85M 50.64M 47.65M 43.53M 81.43M 5.56B 81.65M 563M 218M 2.85B 221M 216M 9.18B 66.18M 56.95M 53.58M 48.95M 91.56M 6.25B 91.81M 633M 246M 3.21B 249M 243M 10.33B
Net income -53.45M -46M -43.27M -39.53M -73.95M -5.05B -74.15M -511M -198M -2.59B -201M -196M -8.34B -52.14M -44.86M -42.21M -38.56M -72.13M -4.92B -72.33M -499M -194M -2.53B -196M -192M -8.14B
Net Debt 10.5M 9.04M 8.5M 7.77M 14.53M 992M 14.57M 100M 38.99M 509M 39.44M 38.58M 1.64B 42.94M 36.95M 34.76M 31.76M 59.41M 4.05B 59.57M 411M 159M 2.08B 161M 158M 6.7B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
04/09/26 US$3.050 +1.33% 856,028
03/09/26 US$3.010 -1.95% 614,544
02/09/26 US$3.070 +0.99% 530,032
01/09/26 US$3.040 +2.70% 780,721
31/08/26 US$2.960 +0.34% 737,784
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
3.050USD
Average target price
4.583USD
Spread / Average Target
+50.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock